Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ·Healthcare·Biotechnology
$13.71
+3.20%
Mkt Cap $309.01M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+45.9%
Consensus $20.00 vs current $13.71
NASDAQ·Healthcare·Biotechnology
$13.71
+3.20%
Mkt Cap $309.01M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$20.00
Range $20.00 – $20.00
+45.9%
Consensus $20.00 vs current $13.71